Overview
Benjamin Tillman is a Hematologist Oncology specialist and a Hematologist in Nashville, Tennessee. Dr. Tillman is rated as an Experienced provider by MediFind in the treatment of Heyde Syndrome. His top areas of expertise are Protein S Deficiency, Protein C Deficiency, Hereditary Resistance to Anti-Vitamin K, Congenital Antithrombin 3 Deficiency, and Bone Marrow Aspiration. Dr. Tillman is currently accepting new patients.
His clinical research consists of co-authoring 18 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
3601 The Vanderbilt Clinic, Nashville, TN 37232
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Vanderbilt Health Clinicians, LLC
Michelle Chi is a Hematologist Oncology specialist and a Hematologist in Nashville, Tennessee. Dr. Chi is rated as an Advanced provider by MediFind in the treatment of Heyde Syndrome. Her top areas of expertise are Heyde Syndrome, Von Willebrand Disease (VWD), Hemophilic Arthropathy, and Hemophilia A. Dr. Chi is currently accepting new patients.
Tennessee Oncology PLLC
Jennifer Green is a Hematologist Oncology specialist and an Oncologist in Franklin, Tennessee. Dr. Green is rated as a Distinguished provider by MediFind in the treatment of Heyde Syndrome. Her top areas of expertise are Hemophilic Arthropathy, Hemophilia A, Heyde Syndrome, Von Willebrand Disease (VWD), and Bone Marrow Aspiration. Dr. Green is currently accepting new patients.
Tennessee Oncology PLLC
Carl Willis is a Hematologist Oncology specialist and an Oncologist in Nashville, Tennessee. Dr. Willis is rated as a Distinguished provider by MediFind in the treatment of Heyde Syndrome. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, HER-2 Positive Breast Cancer, and Inflammatory Breast Cancer. Dr. Willis is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Blood ClotsDr. Tillman isAdvanced. Learn about Blood Clots.
- Congenital Antithrombin 3 Deficiency
- Hereditary Resistance to Anti-Vitamin K
- Protein C DeficiencyDr. Tillman isAdvanced. Learn about Protein C Deficiency.
- Protein S DeficiencyDr. Tillman isAdvanced. Learn about Protein S Deficiency.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Tillman isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Mountain SicknessDr. Tillman isExperienced. Learn about Acute Mountain Sickness.
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Tillman isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Acute Myelomonocytic LeukemiaDr. Tillman isExperienced. Learn about Acute Myelomonocytic Leukemia.